25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

APH (Alliance Pharma plc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Alliance Pharma plc together

I guess you are interested in Alliance Pharma plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Alliance Pharma plc’s Financial Insights
  • 📈 Technical Analysis (TA) – Alliance Pharma plc’s Price Targets

I'm going to help you getting a better view of Alliance Pharma plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Alliance Pharma plc

I send you an email if I find something interesting about Alliance Pharma plc.

1. Quick Overview

1.1. Quick analysis of Alliance Pharma plc (30 sec.)










1.2. What can you expect buying and holding a share of Alliance Pharma plc? (30 sec.)

How much money do you get?

How much money do you get?
p0.00
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
p38.41
Expected worth in 1 year
p30.84
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
p-7.57
Return On Investment
-11.7%

For what price can you sell your share?

Current Price per Share
p64.70
Expected price per share
p64.50 - p65.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Alliance Pharma plc (5 min.)




Live pricePrice per Share (EOD)
p64.70
Intrinsic Value Per Share
p25.29 - p74.52
Total Value Per Share
p63.70 - p112.93

2.2. Growth of Alliance Pharma plc (5 min.)




Is Alliance Pharma plc growing?

Current yearPrevious yearGrowGrow %
How rich?$285.4m$299.5m-$14m-4.9%

How much money is Alliance Pharma plc making?

Current yearPrevious yearGrowGrow %
Making money-$14.7m-$45.5m$30.8m208.8%
Net Profit Margin-6.0%-18.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Alliance Pharma plc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Alliance Pharma plc?

Welcome investor! Alliance Pharma plc's management wants to use your money to grow the business. In return you get a share of Alliance Pharma plc.

First you should know what it really means to hold a share of Alliance Pharma plc. And how you can make/lose money.

Speculation

The Price per Share of Alliance Pharma plc is p64.70. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alliance Pharma plc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alliance Pharma plc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p38.41. Based on the TTM, the Book Value Change Per Share is p-1.89 per quarter. Based on the YOY, the Book Value Change Per Share is p-12.45 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alliance Pharma plc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps-0.030.0%-0.030.0%-0.08-0.1%-0.04-0.1%-0.010.0%0.020.0%
Usd Book Value Change Per Share-0.030.0%-0.030.0%-0.17-0.3%-0.06-0.1%-0.03-0.1%0.030.1%
Usd Dividend Per Share0.000.0%0.000.0%0.020.0%0.020.0%0.020.0%0.010.0%
Usd Total Gains Per Share-0.030.0%-0.030.0%-0.15-0.2%-0.05-0.1%-0.020.0%0.050.1%
Usd Price Per Share0.63-0.63-0.56-0.64-0.92-0.89-
Price to Earnings Ratio-23.05--23.05--6.61-93.03-83.74-50.17-
Price-to-Total Gains Ratio-24.18--24.18--3.79--1.77-21.60-15.62-
Price to Book Ratio1.19-1.19-1.00-1.07-1.39-1.47-
Price-to-Total Gains Ratio-24.18--24.18--3.79--1.77-21.60-15.62-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.8894956
Number of shares1124
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share-0.03-0.03
Usd Total Gains Per Share-0.03-0.02
Gains per Quarter (1124 shares)-29.24-20.86
Gains per Year (1124 shares)-116.96-83.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-117-12769-152-93
20-234-244137-304-176
30-351-361206-456-259
40-468-478275-609-342
50-585-595344-761-425
60-702-712412-913-508
70-819-829481-1065-591
80-936-946550-1217-674
90-1053-1063618-1369-757
100-1170-1180687-1522-840

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%21.07.00.075.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%23.05.00.082.1%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%9.00.01.090.0%14.00.014.050.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%23.05.00.082.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Alliance Pharma plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.892-1.8920%-12.450+558%-4.558+141%-2.462+30%2.532-175%
Book Value Per Share--38.41238.4120%40.305-5%43.824-12%47.107-18%43.374-11%
Current Ratio--2.8432.8430%2.566+11%2.551+11%2.442+16%1.820+56%
Debt To Asset Ratio--0.4370.4370%0.475-8%0.459-5%0.453-3%0.425+3%
Debt To Equity Ratio--0.7780.7780%0.904-14%0.850-9%0.829-6%0.747+4%
Dividend Per Share----0%1.774-100%1.149-100%1.112-100%1.064-100%
Enterprise Value--11817395232.00011817395232.0000%4431523648.000+167%7781737293.333+52%18122208576.320-35%19354631541.920-39%
Eps---1.985-1.9850%-6.130+209%-2.648+33%-1.022-49%1.394-242%
Ev To Ebitda Ratio--30.58330.5830%-1.531+105%6.532+368%8.700+252%7.925+286%
Ev To Sales Ratio--0.6610.6610%0.245+169%0.443+49%1.177-44%1.603-59%
Free Cash Flow Per Share--7.0077.0070%5.682+23%5.474+28%5.874+19%2.270+209%
Free Cash Flow To Equity Per Share--1.2931.2930%-1.569+221%1.100+18%4.045-68%3.722-65%
Gross Profit Margin--1.0001.0000%1.175-15%1.058-6%1.035-3%1.018-2%
Intrinsic Value_10Y_max--74.521----------
Intrinsic Value_10Y_min--25.286----------
Intrinsic Value_1Y_max--6.231----------
Intrinsic Value_1Y_min--2.360----------
Intrinsic Value_3Y_max--19.664----------
Intrinsic Value_3Y_min--7.284----------
Intrinsic Value_5Y_max--34.234----------
Intrinsic Value_5Y_min--12.381----------
Market Cap34974621235.200+29%24730895232.00024730895232.0000%21892923648.000+13%25174570626.667-2%36376668576.320-32%34870201541.920-29%
Net Profit Margin---0.060-0.0600%-0.183+206%-0.123+106%-0.053-12%0.080-175%
Operating Margin---0.033-0.0330%-0.217+567%-0.120+267%-0.022-33%0.127-126%
Operating Ratio--1.0451.0450%1.213-14%1.029+2%0.940+11%0.841+24%
Pb Ratio1.684+29%1.1911.1910%1.005+19%1.067+12%1.395-15%1.471-19%
Pe Ratio-32.598-41%-23.051-23.0510%-6.607-71%93.034-125%83.743-128%50.168-146%
Price Per Share64.700+29%45.75045.7500%40.500+13%46.417-1%67.130-32%64.425-29%
Price To Free Cash Flow Ratio9.234+29%6.5306.5300%7.128-8%9.283-30%11.695-44%12.153-46%
Price To Total Gains Ratio-34.192-41%-24.177-24.1770%-3.794-84%-1.772-93%21.597-212%15.620-255%
Quick Ratio--2.1452.1450%1.827+17%1.891+13%1.766+21%1.281+67%
Return On Assets---0.029-0.0290%-0.080+175%-0.049+70%-0.024-19%0.017-267%
Return On Equity---0.052-0.0520%-0.152+194%-0.092+79%-0.045-14%0.026-297%
Total Gains Per Share---1.892-1.8920%-10.676+464%-3.409+80%-1.350-29%3.596-153%
Usd Book Value--285468971.200285468971.2000%299531800.400-5%326825704.800-13%351019985.120-19%322814450.840-12%
Usd Book Value Change Per Share---0.026-0.0260%-0.171+558%-0.063+141%-0.034+30%0.035-175%
Usd Book Value Per Share--0.5280.5280%0.554-5%0.602-12%0.648-18%0.596-11%
Usd Dividend Per Share----0%0.024-100%0.016-100%0.015-100%0.015-100%
Usd Enterprise Value--162465549.650162465549.6500%60924587.113+167%106983324.309+52%249144123.507-35%266087474.438-39%
Usd Eps---0.027-0.0270%-0.084+209%-0.036+33%-0.014-49%0.019-242%
Usd Free Cash Flow--52070550.00052070550.0000%42225607.200+23%40764653.067+28%43728538.560+19%16907702.840+208%
Usd Free Cash Flow Per Share--0.0960.0960%0.078+23%0.075+28%0.081+19%0.031+209%
Usd Free Cash Flow To Equity Per Share--0.0180.0180%-0.022+221%0.015+18%0.056-68%0.051-65%
Usd Market Cap480831092.742+29%340000347.650340000347.6500%300983914.313+13%346099996.975-2%500106439.587-32%479395530.798-29%
Usd Price Per Share0.889+29%0.6290.6290%0.557+13%0.638-1%0.923-32%0.886-29%
Usd Profit---14750229.200-14750229.2000%-45555372.800+209%-29820786.800+102%-13672935.920-7%7332220.840-301%
Usd Revenue--245863732.800245863732.8000%248398864.000-1%241475371.200+2%225450702.400+9%181877241.280+35%
Usd Total Gains Per Share---0.026-0.0260%-0.147+464%-0.047+80%-0.019-29%0.049-153%
 EOD+4 -4MRQTTM+0 -0YOY+30 -103Y+28 -125Y+15 -2510Y+11 -29

3.3 Fundamental Score

Let's check the fundamental score of Alliance Pharma plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-32.598
Price to Book Ratio (EOD)Between0-11.684
Net Profit Margin (MRQ)Greater than0-0.060
Operating Margin (MRQ)Greater than0-0.033
Quick Ratio (MRQ)Greater than12.145
Current Ratio (MRQ)Greater than12.843
Debt to Asset Ratio (MRQ)Less than10.437
Debt to Equity Ratio (MRQ)Less than10.778
Return on Equity (MRQ)Greater than0.15-0.052
Return on Assets (MRQ)Greater than0.05-0.029
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Alliance Pharma plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5071.618
Ma 20Greater thanMa 5064.475
Ma 50Greater thanMa 10064.078
Ma 100Greater thanMa 20060.466
OpenGreater thanClose64.700
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Alliance Pharma plc

Alliance Pharma plc, a holding company, acquires, markets, and distributes consumer healthcare products and prescription medicines in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. It provides its products under the Aloclair, Anbesol, Asthon & Parsons, Forceval, Hydromol, Kelo-Cote, MacuShield, Vamousse, Nizoral, and Amberen brand names. The company was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom. As of May 14, 2025, Alliance Pharma plc was taken private.

Fundamental data was last updated by Penke on 2025-06-21 02:32:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Alliance Pharma plc earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -6.0% means that -0.06 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alliance Pharma plc:

  • The MRQ is -6.0%. The company is making a loss. -1
  • The TTM is -6.0%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-6.0%TTM-6.0%0.0%
TTM-6.0%YOY-18.3%+12.3%
TTM-6.0%5Y-5.3%-0.7%
5Y-5.3%10Y8.0%-13.3%
4.3.1.2. Return on Assets

Shows how efficient Alliance Pharma plc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.9% Return on Assets means that Alliance Pharma plc generated -0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alliance Pharma plc:

  • The MRQ is -2.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.9%TTM-2.9%0.0%
TTM-2.9%YOY-8.0%+5.1%
TTM-2.9%5Y-2.4%-0.5%
5Y-2.4%10Y1.7%-4.1%
4.3.1.3. Return on Equity

Shows how efficient Alliance Pharma plc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -5.2% Return on Equity means Alliance Pharma plc generated -0.05 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alliance Pharma plc:

  • The MRQ is -5.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.2%TTM-5.2%0.0%
TTM-5.2%YOY-15.2%+10.0%
TTM-5.2%5Y-4.5%-0.7%
5Y-4.5%10Y2.6%-7.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Alliance Pharma plc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Alliance Pharma plc is operating .

  • Measures how much profit Alliance Pharma plc makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -3.3% means the company generated -0.03  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alliance Pharma plc:

  • The MRQ is -3.3%. The company is operating very inefficient. -2
  • The TTM is -3.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-3.3%TTM-3.3%0.0%
TTM-3.3%YOY-21.7%+18.5%
TTM-3.3%5Y-2.2%-1.1%
5Y-2.2%10Y12.7%-14.8%
4.3.2.2. Operating Ratio

Measures how efficient Alliance Pharma plc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.05 means that the operating costs are 1.05 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Alliance Pharma plc:

  • The MRQ is 1.045. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.045. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.045TTM1.0450.000
TTM1.045YOY1.213-0.167
TTM1.0455Y0.940+0.106
5Y0.94010Y0.841+0.098
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Alliance Pharma plc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Alliance Pharma plc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.84 means the company has 2.84 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Alliance Pharma plc:

  • The MRQ is 2.843. The company is able to pay all its short-term debts. +1
  • The TTM is 2.843. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.843TTM2.8430.000
TTM2.843YOY2.566+0.278
TTM2.8435Y2.442+0.402
5Y2.44210Y1.820+0.622
4.4.3.2. Quick Ratio

Measures if Alliance Pharma plc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.14 means the company can pay off 2.14 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alliance Pharma plc:

  • The MRQ is 2.145. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.145. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.145TTM2.1450.000
TTM2.145YOY1.827+0.318
TTM2.1455Y1.766+0.379
5Y1.76610Y1.281+0.485
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Alliance Pharma plc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Alliance Pharma plc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alliance Pharma plc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.44 means that Alliance Pharma plc assets are financed with 43.7% credit (debt) and the remaining percentage (100% - 43.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Alliance Pharma plc:

  • The MRQ is 0.437. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.437. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.437TTM0.4370.000
TTM0.437YOY0.475-0.037
TTM0.4375Y0.453-0.015
5Y0.45310Y0.425+0.028
4.5.4.2. Debt to Equity Ratio

Measures if Alliance Pharma plc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 77.8% means that company has 0.78 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alliance Pharma plc:

  • The MRQ is 0.778. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.778. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.778TTM0.7780.000
TTM0.778YOY0.904-0.127
TTM0.7785Y0.829-0.051
5Y0.82910Y0.747+0.081
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Alliance Pharma plc generates.

  • Above 15 is considered overpriced but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -23.05 means the investor is paying -23.05 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alliance Pharma plc:

  • The EOD is -32.598. Based on the earnings, the company is expensive. -2
  • The MRQ is -23.051. Based on the earnings, the company is expensive. -2
  • The TTM is -23.051. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-32.598MRQ-23.051-9.548
MRQ-23.051TTM-23.0510.000
TTM-23.051YOY-6.607-16.444
TTM-23.0515Y83.743-106.794
5Y83.74310Y50.168+33.575
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Alliance Pharma plc:

  • The EOD is 9.234. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.530. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 6.530. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD9.234MRQ6.530+2.705
MRQ6.530TTM6.5300.000
TTM6.530YOY7.128-0.598
TTM6.5305Y11.695-5.165
5Y11.69510Y12.153-0.458
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Alliance Pharma plc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Alliance Pharma plc:

  • The EOD is 1.684. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.191. Based on the equity, the company is underpriced. +1
  • The TTM is 1.191. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.684MRQ1.191+0.493
MRQ1.191TTM1.1910.000
TTM1.191YOY1.005+0.186
TTM1.1915Y1.395-0.204
5Y1.39510Y1.471-0.076
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets369,139
Total Liabilities161,495
Total Stockholder Equity207,644
 As reported
Total Liabilities 161,495
Total Stockholder Equity+ 207,644
Total Assets = 369,139

Assets

Total Assets369,139
Total Current Assets104,328
Long-term Assets264,811
Total Current Assets
Cash And Cash Equivalents 32,360
Net Receivables 46,338
Inventory 22,519
Other Current Assets 3,111
Total Current Assets  (as reported)104,328
Total Current Assets  (calculated)104,328
+/-0
Long-term Assets
Property Plant Equipment 5,436
Goodwill 12,745
Intangible Assets 240,863
Long-term Assets Other 122
Long-term Assets  (as reported)264,811
Long-term Assets  (calculated)259,166
+/- 5,645

Liabilities & Shareholders' Equity

Total Current Liabilities36,691
Long-term Liabilities124,804
Total Stockholder Equity207,644
Total Current Liabilities
Short-term Debt 596
Accounts payable 13,700
Other Current Liabilities 18,372
Total Current Liabilities  (as reported)36,691
Total Current Liabilities  (calculated)32,668
+/- 4,023
Long-term Liabilities
Long term Debt 92,477
Capital Lease Obligations 3,219
Long-term Liabilities Other 199
Long-term Liabilities  (as reported)124,804
Long-term Liabilities  (calculated)95,895
+/- 28,909
Total Stockholder Equity
Common Stock5,406
Retained Earnings 32,637
Other Stockholders Equity 169,601
Total Stockholder Equity (as reported)207,644
Total Stockholder Equity (calculated)207,644
+/-0
Other
Capital Stock5,406
Cash and Short Term Investments 32,360
Common Stock Shares Outstanding 540,484
Liabilities and Stockholders Equity 369,139
Net Debt 63,336
Net Invested Capital 300,121
Net Working Capital 67,637
Property Plant and Equipment Gross 12,826
Short Long Term Debt Total 95,696



6.2. Balance Sheets Structured

Currency in GBP. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312005-02-282004-02-292003-02-282002-12-312002-02-282001-02-282000-02-291999-02-28
> Total Assets 
6,568
4,354
3,987
8,824
2,261
20,815
26,439
34,296
35,761
48,067
46,406
48,832
56,800
77,398
82,286
100,626
106,991
107,868
292,194
320,737
336,475
403,609
407,637
508,853
503,488
537,411
414,923
369,139
369,139414,923537,411503,488508,853407,637403,609336,475320,737292,194107,868106,991100,62682,28677,39856,80048,83246,40648,06735,76134,29626,43920,8152,2618,8243,9874,3546,568
   > Total Current Assets 
4,426
2,422
2,201
2,583
2,261
3,764
8,303
5,894
5,774
8,308
6,992
8,651
11,733
16,223
15,391
20,172
16,895
15,670
27,769
49,283
49,127
58,747
65,037
77,239
81,021
105,481
104,095
104,328
104,328104,095105,48181,02177,23965,03758,74749,12749,28327,76915,67016,89520,17215,39116,22311,7338,6516,9928,3085,7745,8948,3033,7642,2612,5832,2012,4224,426
       Cash And Cash Equivalents 
2,040
23
0
0
2,247
206
4,579
1,275
0
232
672
4
1,104
1,989
1,079
4,634
888
1,434
3,229
7,221
11,184
10,893
17,830
28,898
29,061
31,714
22,436
32,360
32,36022,43631,71429,06128,89817,83010,89311,1847,2213,2291,4348884,6341,0791,9891,104467223201,2754,5792062,24700232,040
       Net Receivables 
0
0
0
0
-3,544
0
1,741
1
2,714
4,775
0
0
0
0
8,329
9,795
9,837
7,869
11,105
24,596
23,695
29,148
30,289
24,216
27,719
48,230
51,687
46,338
46,33851,68748,23027,71924,21630,28929,14823,69524,59611,1057,8699,8379,7958,32900004,7752,71411,7410-3,5440000
       Inventory 
1,113
1,384
1,434
1,674
0
1,928
1,740
2,469
2,740
2,852
1,881
2,265
2,972
4,544
5,652
5,393
5,468
5,914
12,910
15,356
14,248
18,706
15,518
22,917
21,075
24,286
25,711
22,519
22,51925,71124,28621,07522,91715,51818,70614,24815,35612,9105,9145,4685,3935,6524,5442,9722,2651,8812,8522,7402,4691,7401,92801,6741,4341,3841,113
       Other Current Assets 
1,273
1,015
767
909
1,630
0
1,984
2,149
3,034
5,224
230
186
276
439
331
350
903
453
525
2,110
23,695
29,148
1,400
1,208
3,166
1,251
4,261
3,111
3,1114,2611,2513,1661,2081,40029,14823,6952,1105254539033503314392761862305,2243,0342,1491,98401,6309097671,0151,273
   > Long-term Assets 
2,142
1,932
1,786
6,241
0
17,051
18,136
28,402
29,987
39,759
39,414
40,181
45,067
61,175
66,895
80,454
90,096
92,198
264,425
271,454
287,348
344,862
342,600
431,614
422,467
431,930
310,828
264,811
264,811310,828431,930422,467431,614342,600344,862287,348271,454264,42592,19890,09680,45466,89561,17545,06740,18139,41439,75929,98728,40218,13617,05106,2411,7861,9322,142
       Property Plant Equipment 
72
70
133
138
0
214
148
307
281
297
254
161
132
888
765
564
592
396
1,013
1,806
3,377
7,594
11,554
15,921
4,826
5,578
5,721
5,436
5,4365,7215,5784,82615,92111,5547,5943,3771,8061,01339659256476588813216125429728130714821401381337072
       Goodwill 
0
0
0
0
0
0
0
0
1,129
1,129
1,144
1,144
1,144
1,744
1,744
3,593
3,593
3,593
26,035
16,197
16,565
16,565
16,532
31,260
31,238
21,530
14,487
12,745
12,74514,48721,53031,23831,26016,53216,56516,56516,19726,0353,5933,5933,5931,7441,7441,1441,1441,1441,1291,12900000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
976
1,271
1,465
1,464
1,483
0
0
0
0
0
0
0
00000001,4831,4641,4651,2719760000000000000000
       Intangible Assets 
2,070
1,862
1,653
6,103
0
16,837
17,988
28,095
28,577
38,333
38,016
38,806
43,791
58,543
64,386
76,297
85,468
85,282
233,910
248,636
262,058
318,678
312,128
381,612
382,506
400,100
285,491
240,863
240,863285,491400,100382,506381,612312,128318,678262,058248,636233,91085,28285,46876,29764,38658,54343,79138,80638,01638,33328,57728,09517,98816,83706,1031,6531,8622,070
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,835
2,087
2,978
4,055
4,590
2,793
2,386
2,821
3,897
4,722
0
0
004,7223,8972,8212,3862,7934,5904,0552,9782,0871,8350000000000000000
> Total Liabilities 
6,454
3,903
3,392
8,286
24
21,009
24,214
27,471
28,257
37,635
39,740
40,067
40,170
41,317
38,158
48,778
42,323
37,088
129,752
141,474
133,098
151,410
133,457
227,895
221,002
249,750
197,050
161,495
161,495197,050249,750221,002227,895133,457151,410133,098141,474129,75237,08842,32348,77838,15841,31740,17040,06739,74037,63528,25727,47124,21421,009248,2863,3923,9036,454
   > Total Current Liabilities 
6,454
3,808
3,325
3,462
24
5,136
5,463
5,867
6,117
11,034
9,766
11,142
11,447
16,978
13,859
22,045
14,949
11,415
31,755
50,277
60,810
91,723
24,206
30,186
40,577
47,022
40,570
36,691
36,69140,57047,02240,57730,18624,20691,72360,81050,27731,75511,41514,94922,04513,85916,97811,44711,1429,76611,0346,1175,8675,4635,136243,4623,3253,8086,454
       Short-term Debt 
1,402
8
87
1,091
0
1,941
2,030
2,460
1,833
3,031
1,716
2,295
3,114
4,001
4,250
10,440
5,020
3,309
15,807
25,782
42,298
68,482
1,025
964
456
613
768
596
5967686134569641,02568,48242,29825,78215,8073,3095,02010,4404,2504,0013,1142,2951,7163,0311,8332,4602,0301,94101,0918781,402
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,901
2,895
15,776
25,782
41,719
68,035
0
0
0
0
0
0
00000068,03541,71925,78215,7762,89525,9010000000000000000
       Accounts payable 
4,886
3,156
2,684
2,125
2,847
0
2,708
2,426
3,427
3,298
2,151
2,553
1,690
3,799
1,194
902
1,118
1,693
1,153
5,655
6,662
8,978
6,970
11,275
8,341
18,567
18,225
13,700
13,70018,22518,5678,34111,2756,9708,9786,6625,6551,1531,6931,1189021,1943,7991,6902,5532,1513,2983,4272,4262,70802,8472,1252,6843,1564,886
       Other Current Liabilities 
166
644
554
160
2,287
0
711
980
859
4,209
2,710
5,463
5,386
7,348
6,505
8,156
6,534
4,485
11,815
15,267
9,088
10,998
10,620
14,072
30,602
24,858
19,123
18,372
18,37219,12324,85830,60214,07210,62010,9989,08815,26711,8154,4856,5348,1566,5057,3485,3865,4632,7104,20985998071102,287160554644166
   > Long-term Liabilities 
0
95
67
4,824
10
15,873
18,751
21,604
22,140
26,601
29,974
28,925
28,723
24,339
24,299
26,733
27,374
25,673
97,997
91,197
72,288
59,687
109,251
197,709
180,425
202,728
156,480
124,804
124,804156,480202,728180,425197,709109,25159,68772,28891,19797,99725,67327,37426,73324,29924,33928,72328,92529,97426,60122,14021,60418,75115,873104,82467950
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,493
6,309
29,334
33,259
30,445
29,043
30,214
56,650
61,728
0
0
0
00061,72856,65030,21429,04330,44533,25929,3346,3096,4930000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
373
431
438
704
725
768
0
0
0
0
0
0
0000007687257044384313730000000000000000
> Total Stockholder Equity
114
451
595
538
2,237
0
2,225
6,825
7,504
10,432
6,666
8,765
16,630
36,081
44,128
51,848
64,668
70,780
162,442
179,263
203,377
252,199
274,180
280,958
282,486
287,661
217,873
207,644
207,644217,873287,661282,486280,958274,180252,199203,377179,263162,44270,78064,66851,84844,12836,08116,6308,7656,66610,4327,5046,8252,22502,237538595451114
   Common Stock
20
270
281
281
150
0
1,108
1,474
1,474
1,621
1,621
1,621
1,933
2,361
2,401
2,430
2,641
2,641
4,682
4,726
4,750
5,182
5,294
5,329
5,382
5,400
5,404
5,406
5,4065,4045,4005,3825,3295,2945,1824,7504,7264,6822,6412,6412,4302,4012,3611,9331,6211,6211,6211,4741,4741,108015028128127020
   Retained Earnings 
94
181
307
251
-106
-481
-3,769
-3,363
-2,702
-2,200
-5,410
-2,899
1,208
9,494
16,771
23,658
31,202
37,188
47,237
60,177
83,358
95,099
112,513
117,703
116,418
108,238
43,366
32,637
32,63743,366108,238116,418117,703112,51395,09983,35860,17747,23737,18831,20223,65816,7719,4941,208-2,899-5,410-2,200-2,702-3,363-3,769-481-10625130718194
   Capital Surplus 0000000000000000000000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
0
0
7
6
2,569
0
5,215
8,702
8,732
11,011
11,001
11,275
14,674
24,226
24,956
25,760
29,380
29,388
108,308
109,594
110,638
144,639
149,036
150,645
160,686
174,023
169,103
169,601
169,601169,103174,023160,686150,645149,036144,639110,638109,594108,30829,38829,38025,76024,95624,22614,67411,27511,00111,0118,7328,7025,21502,5696700



6.3. Balance Sheets

Currency in GBP. All numbers in thousands.




6.4. Cash Flows

Currency in GBP. All numbers in thousands.




6.5. Income Statements

Currency in GBP. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in GBP. All numbers in thousands.

Gross Profit (+$)
totalRevenue178,836
Cost of Revenue-69,550
Gross Profit109,286109,286
 
Operating Income (+$)
Gross Profit109,286
Operating Expense-117,384
Operating Income-8,098-8,098
 
Operating Expense (+$)
Research Development0
Selling General Administrative70,848
Selling And Marketing Expenses0
Operating Expense117,38470,848
 
Net Interest Income (+$)
Interest Income62
Interest Expense-8,629
Other Finance Cost-319
Net Interest Income-8,886
 
Pretax Income (+$)
Operating Income-8,098
Net Interest Income-8,886
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-14,460-1,736
EBIT - interestExpense = -14,460
-14,460
-2,100
Interest Expense8,629
Earnings Before Interest and Taxes (EBIT)-5,831-5,831
Earnings Before Interest and Taxes (EBITDA)3,864
 
After tax Income (+$)
Income Before Tax-14,460
Tax Provision--3,731
Net Income From Continuing Ops-10,729-10,729
Net Income-10,729
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses186,934
Total Other Income/Expenses Net-6,3628,886
 

Technical Analysis of Alliance Pharma plc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alliance Pharma plc. The general trend of Alliance Pharma plc is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alliance Pharma plc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Alliance Pharma plc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Alliance Pharma plc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 65.00 < 65.00 < 65.00.

The bearish price targets are: 64.50 > 64.50 > 64.50.

Know someone who trades $APH? Share this with them.👇

Alliance Pharma plc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Alliance Pharma plc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Alliance Pharma plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Alliance Pharma plc. The current macd is 0.22323981.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alliance Pharma plc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Alliance Pharma plc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Alliance Pharma plc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Alliance Pharma plc Daily Moving Average Convergence/Divergence (MACD) ChartAlliance Pharma plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Alliance Pharma plc. The current adx is 48.92.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Alliance Pharma plc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Alliance Pharma plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Alliance Pharma plc. The current sar is 62.97.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Alliance Pharma plc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Alliance Pharma plc. The current rsi is 71.62. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -1/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
Alliance Pharma plc Daily Relative Strength Index (RSI) ChartAlliance Pharma plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Alliance Pharma plc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alliance Pharma plc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Alliance Pharma plc Daily Stochastic Oscillator ChartAlliance Pharma plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Alliance Pharma plc. The current cci is 96.93.

Alliance Pharma plc Daily Commodity Channel Index (CCI) ChartAlliance Pharma plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Alliance Pharma plc. The current cmo is 40.82.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Alliance Pharma plc Daily Chande Momentum Oscillator (CMO) ChartAlliance Pharma plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Alliance Pharma plc. The current willr is -42.85714286.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Alliance Pharma plc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Alliance Pharma plc Daily Williams %R ChartAlliance Pharma plc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Alliance Pharma plc.

Alliance Pharma plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Alliance Pharma plc. The current atr is 0.26507315.

Alliance Pharma plc Daily Average True Range (ATR) ChartAlliance Pharma plc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Alliance Pharma plc. The current obv is 179,959,813.

Alliance Pharma plc Daily On-Balance Volume (OBV) ChartAlliance Pharma plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Alliance Pharma plc. The current mfi is 97.75.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Alliance Pharma plc Daily Money Flow Index (MFI) ChartAlliance Pharma plc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Alliance Pharma plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Alliance Pharma plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Alliance Pharma plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5071.618
Ma 20Greater thanMa 5064.475
Ma 50Greater thanMa 10064.078
Ma 100Greater thanMa 20060.466
OpenGreater thanClose64.700
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Alliance Pharma plc with someone you think should read this too:
  • Are you bullish or bearish on Alliance Pharma plc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alliance Pharma plc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Alliance Pharma plc

I send you an email if I find something interesting about Alliance Pharma plc.


Comments

How you think about this?

Leave a comment

Stay informed about Alliance Pharma plc.

Receive notifications about Alliance Pharma plc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.